BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  Adcomms

  FDA Questions Strength of Evidence Backing Zevra’s Rare Disease Therapy Ahead of Adcomm

  The Genetic Metabolic Diseases Advisory Committee will meet on Friday to discuss Zevra’s modified scale to describe the efficacy of its drug candidate for the treatment of Niemann-Pick disease type C.

  August 1, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Cardiovascular disease

  Lilly’s Tirzepatide Clears Phase III Cardiovascular Study on Heels of Novo

  Eli Lilly on Thursday released late-stage data showing a 38% reduction in the risk of heart failure outcomes, as it plays catch-up with Novo Nordisk’s semaglutide which won the FDA’s cardio nod in March.

  August 1, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System

  August 1, 2024

   · 

  4 min read
• Press Releases

  Veru to Report Fiscal 2024 Third Quarter Financial Results on August 8, 2024

  August 1, 2024

   · 

  10 min read
• Press Releases

  Wave Life Sciences Second Quarter 2024 Financial Results Scheduled for August 8, 2024

  August 1, 2024

   · 

  1 min read
• Press Releases

  Cassava Sciences to Hold Conference Call to Discuss Recent Developments and Provide a Company Update on Thursday, August 8, 2024 at 8:30 am ET

  August 1, 2024

   · 

  1 min read
• Press Releases

  Corvus Pharmaceuticals Granted FDA Fast Track Designation for Soquelitinib for Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

  August 1, 2024

   · 

  6 min read
• Press Releases

  Intelligent Bio Solutions Partners with CenExel to Conduct Clinical Study as Part of FDA 510(k) Pathway

  August 1, 2024

   · 

  4 min read
• Press Releases

  Entera’s EB613, the First Once Daily PTH(1-34) Tablet Treatment Dedicated to Post-Menopausal Women with High Risk Osteoporosis Abstract Selected for Presentation at the ASBMR 2024 Annual Meeting - Key SABRE Update Also Expected

  August 1, 2024

   · 

  6 min read
• Press Releases

  Mycovia Pharmaceuticals Announces Presentation of Results from Three Safety Studies Evaluating VIVJOA® (oteseconazole) in Subjects with Renal or Hepatic Impairment, and the Impact on QT Prolongation at the 2024 IDSOG Annual Meeting

  August 1, 2024

   · 

  6 min read